1. Home
  2. GLP vs TSHA Comparison

GLP vs TSHA Comparison

Compare GLP & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$42.70

Market Cap

1.5B

Sector

Energy

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.50

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
TSHA
Founded
2005
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
GLP
TSHA
Price
$42.70
$5.50
Analyst Decision
Hold
Strong Buy
Analyst Count
1
9
Target Price
$45.00
$10.22
AVG Volume (30 Days)
41.0K
3.8M
Earning Date
11-07-2025
11-04-2025
Dividend Yield
7.16%
N/A
EPS Growth
N/A
N/A
EPS
2.08
N/A
Revenue
$18,099,776,000.00
$6,310,000.00
Revenue This Year
$22.70
N/A
Revenue Next Year
$42.12
N/A
P/E Ratio
$20.28
N/A
Revenue Growth
4.10
N/A
52 Week Low
$39.70
$1.05
52 Week High
$60.00
$5.95

Technical Indicators

Market Signals
Indicator
GLP
TSHA
Relative Strength Index (RSI) 40.13 59.06
Support Level $41.76 $5.22
Resistance Level $46.00 $5.95
Average True Range (ATR) 1.65 0.34
MACD -0.14 0.05
Stochastic Oscillator 9.91 75.26

Price Performance

Historical Comparison
GLP
TSHA

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: